Early treatment with ensitrelvir in SARS-CoV-2-negative individuals exposed to COVID-19 may help prevent infection.
A new study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2—the virus ...
Live Science on MSN
A pill can stop people from developing COVID after being exposed to the virus, trial finds
A pill called ensitrelvir is the first drug shown to effectively reduce infection after exposure to SARS-CoV-2.
An advisory panel of the U.S. FDA will meet this week to discuss and vote on the design of the next set of COVID-19 vaccines.
Background Although health problems may persist beyond 4 weeks after SARS-CoV-2 infection, evidence on long-term ophthalmic ...
A brain imaging study linked severe long COVID symptoms to increased activity in the hippocampus and amygdala rather than ...
This new research, published in the Genes & Diseases journal by a team from Hunan University, Texas A&M University Colleges ...
India Today on MSN
Ebola vs hantavirus vs SARS Cov2: All you need to know
The World Health Organisation has declared the Ebola outbreak in the DRC and Uganda a global health emergency after the ...
Hosted on MSN
Another coronavirus threat on the way? New international study finds SARS-CoV-2 relatives that can infect humans
It’s been over six years since COVID-19 upended everything, and researchers are raising a new warning: relatives of the SARS-CoV-2 virus are still out there, circulating in animals, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results